The Digital Revolution in Genomics: OptraHEALTH® Launches GeneFAX™, Free to Use Conversational AI Powered App for Consumers

SAN JOSE, Calif.--()--OptraHEALTH®, a leading AI company, launched GeneFAX™ mobile app for genetic testing & counseling at the American Society of Human Genetics Conference (2018) in San Diego, CA. GeneFAX™ is an advanced conversational AI app that allows consumers to ask questions relevant to genetic testing, from understanding the meaning of a test, or what to expect in a test and information about various genetic diseases. GeneFAX™ is free for use and is available for download on app store and for Amazon Alexa.

For consumers who have already undertaken a genetic test and have a report, we can provide even more accurate answers about their own reports. This is accomplished by MyGeneFAX™. Consumers may ask questions about the meaning of the test results for them as well as their family members and obtain highly relevant and contextual information about their report findings.

GeneFAX™ is backed by a highly curated database of genetic diseases, validated by board-certified genetic counselors and supports conversations in both text and in audio.

If a consumer needs additional information they may use CounselorConnect™, a GeneFAX™ add-on with which we connect a consumer with a board-certified genetic counselor.

"We understand that genetic reports are complex, leaving consumers anxious and confused. We believe in the democratization of genomic information for all, and, to provide that, we are giving GeneFAX™ for free use. It has never been so easy to converse and gain so many insights about your genetic test in a contextually relevant, simple and precise manner. GeneFAX™ is powered by Optra’s conversational AI platform which uses natural language processing and machine learning to mine and accurately provides answers about genetic testing, reports, health, and genomics. This is the real digital genetic revolution augmenting the efforts of genetics experts," said Dr. Gauri Naik Ph.D., Founder & CEO.

"As genomic testing becomes less expensive and more common, it will influence innumerable aspects of wellness, reproduction, and healthcare. Scalable technologies that can provide information and answers to consumers are certainly going to be needed to augment the efforts of genetics experts,” says Dr. Robert Green, Professor of Genetics at Harvard Medical School.

About OptraHEALTH:

OptraHEALTH® (www.optrahealth.com) is focused on improving outcomes for consumers and leading Life Sciences and Healthcare organizations by utilizing our next generation Artificial Intelligence platform. With our team of domain experts and a passion for solving complex scientific problems, we help our clients INNOVATE, ACCELERATE and OPTIMIZE.

OptraHEALTH’s GeneFAX™, a conversational AI platform for genomics, provides an engaging and meaningful experience to consumers and is agnostic of genetic reports. A powerful AI engine generates evidence-based responses from continuously mined genetic literature. Follow Us on LinkedIn and Twitter.

Contacts

OptraHEALTH
Ashwin Kotwaliwale MD Ph.D. | Product Manager
408.524.5300 x 409 | info@genefax.ai

Contacts

OptraHEALTH
Ashwin Kotwaliwale MD Ph.D. | Product Manager
408.524.5300 x 409 | info@genefax.ai